Copy number alterations in B-cell development genes, drug resistance, and clinical outcome in pediatric B-cell precursor acute lymphoblastic leukemia.

Sci Rep · 2019 · PMC6420659 · PMID 30874617

Europe PMC DOI

hedged sentence

0.0570

closest p · 1.1× alpha

0.0570

boldest claim

The sentences

showed a trendp = 0.057so close (0.05 < p ≤ 0.1)

Cases that harbored an EBF1 deletion showed a trend towards higher MRD levels after induction therapy compared to non- EBF1 deleted cases (OR = 5.16, p = 0.057; Fig. 3B ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.